These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. A multicomponent macrocyclization strategy to natural product-like cyclic lipopeptides: synthesis and anticancer evaluation of surfactin and mycosubtilin analogues. Morejón MC; Laub A; Kaluđerović GN; Puentes AR; Hmedat AN; Otero-González AJ; Rivera DG; Wessjohann LA Org Biomol Chem; 2017 May; 15(17):3628-3637. PubMed ID: 28406518 [TBL] [Abstract][Full Text] [Related]
63. Semisynthetic head-to-tail cyclized peptides obtained by combining protein Palei S; Mootz HD Chem Commun (Camb); 2021 Apr; 57(34):4194-4197. PubMed ID: 33908454 [TBL] [Abstract][Full Text] [Related]
64. Structure-Based Virtual Screening, Compound Synthesis, and Bioassay for the Design of Chitinase Inhibitors. Dong Y; Jiang X; Liu T; Ling Y; Yang Q; Zhang L; He X J Agric Food Chem; 2018 Apr; 66(13):3351-3357. PubMed ID: 29554796 [TBL] [Abstract][Full Text] [Related]
65. Kinetic and crystallographic analyses of the catalytic domain of chitinase from Pyrococcus furiosus- the role of conserved residues in the active site. Tsuji H; Nishimura S; Inui T; Kado Y; Ishikawa K; Nakamura T; Uegaki K FEBS J; 2010 Jun; 277(12):2683-95. PubMed ID: 20553502 [TBL] [Abstract][Full Text] [Related]
66. Structure-Activity Relationship Studies of the Natural Product G Xiong XF; Zhang H; Boesgaard MW; Underwood CR; Bräuner-Osborne H; Strømgaard K ChemMedChem; 2019 Apr; 14(8):865-870. PubMed ID: 30790465 [TBL] [Abstract][Full Text] [Related]
67. A class III chitinase without disulfide bonds from the fern, Pteris ryukyuensis: crystal structure and ligand-binding studies. Kitaoku Y; Umemoto N; Ohnuma T; Numata T; Taira T; Sakuda S; Fukamizo T Planta; 2015 Oct; 242(4):895-907. PubMed ID: 25998529 [TBL] [Abstract][Full Text] [Related]
68. Crystal structures of substrate-bound chitinase from the psychrophilic bacterium Moritella marina and its structure in solution. Malecki PH; Vorgias CE; Petoukhov MV; Svergun DI; Rypniewski W Acta Crystallogr D Biol Crystallogr; 2014 Mar; 70(Pt 3):676-84. PubMed ID: 24598737 [TBL] [Abstract][Full Text] [Related]
69. Pocket-based Lead Optimization Strategy for the Design and Synthesis of Chitinase Inhibitors. Dong Y; Hu S; Jiang X; Liu T; Ling Y; He X; Yang Q; Zhang L J Agric Food Chem; 2019 Apr; 67(13):3575-3582. PubMed ID: 30865442 [TBL] [Abstract][Full Text] [Related]
70. C-H Functionalization of N-Methylated Amino Acids and Peptides as Tool in Natural Product Synthesis: Synthesis of Abyssenine A and Mucronine E. Kinsinger T; Kazmaier U Org Lett; 2018 Dec; 20(23):7726-7730. PubMed ID: 30475630 [TBL] [Abstract][Full Text] [Related]
71. Disabling erbB receptors with rationally designed exocyclic mimetics of antibodies: structure-function analysis. Berezov A; Zhang HT; Greene MI; Murali R J Med Chem; 2001 Aug; 44(16):2565-74. PubMed ID: 11472210 [TBL] [Abstract][Full Text] [Related]
72. Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth Factor. Bayó-Puxan N; Rodríguez-Mias R; Goldflam M; Kotev M; Ciudad S; Hipolito CJ; Varese M; Suga H; Campos-Olivas R; Barril X; Guallar V; Teixidó M; García J; Giralt E ChemMedChem; 2016 Apr; 11(8):928-39. PubMed ID: 26553526 [TBL] [Abstract][Full Text] [Related]
73. [Peptide fragments and structural analogues of chemokine MPC-1: synthesis and effect on the MPC-1-induced migration of monocytes]. Sidorova MB; Molokoedov AS; Aref'eva TI; Kukhtina NB; Krasnikova TL; Bespalova ZhD; Bushuev VN Bioorg Khim; 2004; 30(6):582-93. PubMed ID: 15586809 [TBL] [Abstract][Full Text] [Related]
74. Structural and biological aspects of natural bridged macrobicyclic peptides from marine resources. Dahiya R; Dahiya S; Kumar P; Kumar RV; Dahiya S; Kumar S; Saharan R; Basu P; Mitra A; Sharma A; Kashaw SK; Patel JK Arch Pharm (Weinheim); 2021 Aug; 354(8):e2100034. PubMed ID: 33913195 [TBL] [Abstract][Full Text] [Related]
75. Cyclic tripeptide-based potent human SIRT7 inhibitors. Li S; Wu B; Zheng W Bioorg Med Chem Lett; 2019 Feb; 29(3):461-465. PubMed ID: 30578034 [TBL] [Abstract][Full Text] [Related]
76. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands. Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118 [TBL] [Abstract][Full Text] [Related]
77. The X-ray structure of a chitinase from the pathogenic fungus Coccidioides immitis. Hollis T; Monzingo AF; Bortone K; Ernst S; Cox R; Robertus JD Protein Sci; 2000 Mar; 9(3):544-51. PubMed ID: 10752616 [TBL] [Abstract][Full Text] [Related]
79. Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides. Gurrath M; Müller G; Kessler H; Aumailley M; Timpl R Eur J Biochem; 1992 Dec; 210(3):911-21. PubMed ID: 1483474 [TBL] [Abstract][Full Text] [Related]
80. Total synthesis and biological evaluation of ustiloxin natural products and two analogs. Li P; Evans CD; Forbeck EM; Park H; Bai R; Hamel E; Joullié MM Bioorg Med Chem Lett; 2006 Sep; 16(18):4804-7. PubMed ID: 16837194 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]